Insight Molecular Diagnostics, Inc. (IMDX)
4.14
+0.13
(+3.24%)
USD |
NASDAQ |
Sep 22, 16:00
4.115
-0.02
(-0.60%)
After-Hours: 20:00
Insight Molecular Diagnostics Price : 4.14 for Sept. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | 4.04 | 4.26 | 4.025 | 4.14 | 309269.0 |
| Sep 21, 2026 | 4.09 | 4.13 | 3.84 | 4.01 | 253950.0 |
| Sep 18, 2026 | 3.90 | 4.10 | 3.77 | 4.00 | 317923.0 |
| Sep 17, 2026 | 3.67 | 3.98 | 3.51 | 3.95 | 197737.0 |
| Sep 16, 2026 | 4.03 | 4.205 | 3.50 | 3.58 | 303078.0 |
| Sep 15, 2026 | 3.99 | 4.24 | 3.77 | 4.02 | 213697.0 |
| Sep 14, 2026 | 4.08 | 4.22 | 3.91 | 4.02 | 526826.0 |
| Sep 11, 2026 | 4.06 | 4.228 | 3.94 | 4.20 | 173827.0 |
| Sep 10, 2026 | 4.04 | 4.15 | 3.91 | 3.98 | 119468.0 |
| Sep 09, 2026 | 4.26 | 4.26 | 4.012 | 4.10 | 188810.0 |
| Sep 08, 2026 | 4.13 | 4.321 | 3.85 | 4.27 | 212818.0 |
| Sep 04, 2026 | 4.10 | 4.18 | 3.99 | 4.13 | 183524.0 |
| Sep 03, 2026 | 3.98 | 4.22 | 3.85 | 4.12 | 307816.0 |
| Sep 02, 2026 | 3.81 | 4.04 | 3.71 | 4.01 | 80819.00 |
| Sep 01, 2026 | 3.86 | 3.99 | 3.74 | 3.84 | 128117.0 |
| Aug 31, 2026 | 4.10 | 4.115 | 3.88 | 3.92 | 102404.0 |
| Aug 28, 2026 | 4.245 | 4.48 | 4.10 | 4.13 | 81035.00 |
| Aug 27, 2026 | 4.27 | 4.32 | 4.23 | 4.29 | 36362.00 |
| Aug 26, 2026 | 4.41 | 4.43 | 4.29 | 4.30 | 44538.00 |
| Aug 25, 2026 | 4.35 | 4.54 | 4.35 | 4.44 | 155942.0 |
| Aug 24, 2026 | 4.37 | 4.463 | 4.20 | 4.32 | 83107.00 |
| Aug 21, 2026 | 4.40 | 4.455 | 4.31 | 4.34 | 38690.00 |
| Aug 20, 2026 | 4.36 | 4.435 | 4.20 | 4.30 | 112164.0 |
| Aug 19, 2026 | 4.29 | 4.50 | 4.25 | 4.38 | 146925.0 |
| Aug 18, 2026 | 4.22 | 4.35 | 4.09 | 4.28 | 318061.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.96 |
| Agenus, Inc. | 8.70 |
| Amgen, Inc. | 410.24 |
| Anika Therapeutics, Inc. | 20.89 |
| BioCryst Pharmaceuticals, Inc. | 8.78 |
Price Related Metrics
| PS Ratio | 83.90 |
| Earnings Yield | -35.88% |
| Market Cap | 135.06M |